Identification of risk and protective factors in titin cardiomyopathy

Back

HFA Premium Access

Identification of risk and protective factors in titin cardiomyopathy

Session: From bedside to bench and back

Topic: Pathophysiology

Speaker: Miss S. Stroeks (Maastricht, NL)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Miss Sophie Stroeks

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))

0 follower

6 more presentations in this session

Proteomic clusters of patients with new onset heart failure; more inflammation and worse prognosis in cluster with preserved ejection fraction - the PREFERS Study

Speaker: Assistant Professor C. Hage (Stockholm, SE)

Clonal hematopoiesis has prognostic value in dilated cardiomyopathy independent of age and clone size

Speaker: Mr M. Sikking (Maastricht, NL)

Phospholamban antisense treatment attenuates hallmarks of disease in PLN R14del human iPSC derived cardiomyocytes

Speaker: Mr F. Deiman (Groningen, NL)

Defect in PKA-mediated proteasome activation is a key pathogenic factor for cardiac proteinopathy

Speaker: Professor X. Wang (Vermillion, US)

ATPase inhibitory factor 1 (ATPIF-1) preserves cardiac function during ageing

Speaker: Mr P. Sanchez (Groningen, NL)

Access the full session

From bedside to bench and back

Speakers: Miss S. Stroeks, Assistant Professor C. Hage, Mr M. Sikking, Mr F. Deiman, Professor X. Wang...

Access

Video

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources